Table 1. Clinical outcomes at one year.
| Outcome | OCT (n=153) | IVUS (n=136) | Angiography (n=142) | p-value | |
| OCT vs IVUS | OCT vs angiography | ||||
| MACE | 9.8% (15) | 9.1% (12) | 7.9% (11) | 0.92 | 0.73 |
| Target lesion failure | 2.0% (3) | 3.7% (5) | 1.4% (2) | 0.54 | 0.94 |
| All-cause mortality | 0.0% (0) | 0.0% (0) | 0.0% (0) | – | – |
| All myocardial infarction | 2.6% (4) | 2.2% (3) | 2.3% (3) | 0.96 | 0.94 |
| Procedural | 0.7% (1) | 0.7% (1) | 0.0% (0) | 0.99 | 0.63 |
| Spontaneous | 2.0% (3) | 1.5% (2) | 2.3% (3) | 0.94 | 0.99 |
| Target vessel | 0.7% (1) | 1.5% (1) | 0.7% (1) | 0.80 | 0.99 |
| All revascularisation | 8.5% (13) | 7.6% (10) | 7.9% (11) | 0.89 | 0.94 |
| ID revascularisation | 7.2% (11) | 6.9% (9) | 7.9% (11) | 0.97 | 0.99 |
| ID TLR | 1.3% (2) | 2.9% (4) | 1.4% (2) | 0.49 | 0.99 |
| ID TVR/non-TLR | 2.6% (4) | 2.2% (3) | 1.4% (2) | 0.95 | 0.69 |
| Stent thrombosis | 0.7% (1) | 0.0% (0) | 0.0% (0) | 0.39 | 0.39 |
| ID: ischaemia-driven; IVUS: intravascular ultrasound; MACE: major adverse cardiovascular events; OCT: optical coherence tomography; TLR: target lesion revascularisation; TVR: target vessel revascularisation | |||||